Why Did Cronos Group (TSX:CRON) Stock Trade 9% Lower After Q1 Earnings on Thursday?

Cannabis producer Cronos Group (TSX:CRON)(NASDAQ:CRON) shares traded as low as 9.6% on Thursday after the cash-rich company released a mixed bag of Q1 2019 results before market open. The company actually showed some improvements in its financial performance as compared to a previous quarter, but revenue growth, the market’s main focus today, was much weaker than desirable. Not-so-impressive revenue growth…

Read More

USMJ Confirms Cannabis Logistics Transition Update Schedule

North American Cannabis Holdings, Inc.

DALLAS, May 09, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) today confirmed that on Tuesday, next week, May 14, 2019, CEO Steven Rash will publish an update on the state of the company’s transition into a dedicated cannabis logistics operation. The update will include details on the company’s growing Ecommerce…

Read More

Is Aurora Cannabis (TSX:ACB) Stock a Buy Today?

The 2019 rally in marijuana stocks has investors scouring the cannabis sector to see which marijuana companies might be the best picks to pocket some pot stock gains through the end of the year. Let’s take a look at Aurora Cannabis (TSX:ACB)(NYSE:ACB) to see if it deserves to be on your buy list right now. Big appetite Aurora Cannabis currently…

Read More

WCVC and USMJ Set To Shape Cannabis Edibles Market According To Born2Invest Feature

West Coast Venture Group, Corp.

DENVER, May 09, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE —  West Coast Venture Group, Corp. (OTCQB: WCVC) (“WCVC”) and North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) were featured today by Born2Invest, a digital news organization dedicated to writing about and publishing the business and financial affairs of the world.  The article, Cannabis companies set to rule the edibles market in…

Read More

Kali-Extracts To Present Cannabis Treatment R&D For $170 Million In Pharmaceutical Market Opportunity On April 17th

Kaly1

DALLAS, April 09, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (KALY) (“KALY”) today announced an online presentation scheduled next week for Wednesday, April 17th, where management will provide details on its patented cannabis extract treatments targeting a $170 million pharmaceutical market opportunity currently under development. The company has recently announced ongoing cannabis…

Read More

Is Aurora Cannabis Inc (TSX:ACB) Working on a Big Deal?

Aurora Cannabis (TSX:ACB)(NYSE:ACB) has been making some big, subtle moves lately. In March, the company announced that it was bringing on billionaire investor Nelson Peltz as a strategic advisor. Normally, that’s a vague position and can mean anything and everything. However, in this case, it was noticeably different. For one, Peltz could end up being a big shareholder of the…

Read More

Should You Buy Aphria Inc. (TSX:APHA) Stock Ahead of Earnings?

Aphria (TSX:APHA)(NYSE:APHA) is a heavyweight cannabis producer based in Ontario. Shares of Aphria fell 1.04% on April 8. The stock has climbed 69% in 2019 so far. Aphria stock surged above the $14 mark in early February on the back of significant internal shifts in the company and a broad move up for the cannabis sector. Back in early February,…

Read More

Kali-Extracts Announces Cannabis Treatment For $9 Billion Epilepsy Market Under Development

Kaly1

DALLAS, April 09, 2019 (GLOBE NEWSWIRE) — via OTC PR WIRE — Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced a treatment for epilepsy derived from the company’s patented cannabis extraction method is under research and development. “Doctors involved in research with our extracts have given me feedback that our extracts are superior to those of GW…

Read More

Aurora Cannabis (TSX:ACB) and Aphria (TSX:APHA) Get a Leg Up on the Competition

Fort the most part, marijuana stocks have been bid up for one reason: the legalization of recreational marijuana in Canada. Pot stocks have sky-high valuations, and at the moment, their success as investments is dependent on this recreational demand. Lost amid the recreational hype is medical marijuana. Most pot stocks got their start as licensed medical marijuana producers. Major players,…

Read More

Captor Capital Enters Into Letter of Intent to Acquire Majority Ownership in Michigan Cannabis Opportunity

captor

April 09, 2019 07:59 ET | Source: Captor Capital Corp. 20 retail cannabis licenses Two processing licenses Eight cultivation licenses TORONTO, April 09, 2019 (GLOBE NEWSWIRE) — Captor Capital Corp. (CSE: CPTR; USOTC: CPTRF; FRANKFURT: NMV; STUTTGART: NMVA), (“Captor” or the “Company”), a vertically integrated investment company focused on cannabis, is pleased to announce that it has entered into a…

Read More